Amreen Husain, MD
Academic Appointments
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Stanford Women's Cancer Center 900 Blake Wilbur Dr 1st Floor MC 5854 Palo Alto, CA 94304 Tel Work (650) 498-6004 Fax (650) 723-7448Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailAlternate Contact Patient Appointment Tel Work 650-498-6004Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Gynecologic Cancer
- Cervix Cancer
- Cervix Cancer - Gynecologic Oncology
- Endometrial Cancer
- Endometrial Cancer - Gynecologic Oncology
- Fallopian Tube
Professional Education
| Board Certification: | Gynecologic Oncology, American Board of Obstetrics and Gynecology (2003) |
| Board Certification: | Obstetrics and Gynecology, American Board of Obstetrics and Gynecology (2002) |
| Fellowship: | Memorial Sloan-Kettering Cancer Center, NY USA (2000) |
| Internship: | New York Hospital NY (1992) |
| Medical Education: | New York Medical College NY (1991) |
Community and International Work
- Eritrean Womens' Project, Eritrea
Internet Links
Scientific Focus
Clinical Trials
- Not Recruiting Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
- Not Recruiting Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
- Not Recruiting Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
- Not Recruiting Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
- Not Recruiting Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Publications
- Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports. Int J Gynecol Cancer. 2009; (9): 1521-3
- Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Am J Surg Pathol. 2008; (7): 1029-37
- The impact of chemotherapy on the survival of early-stage I-II epithelial ovarian cancer. Gynecol Oncol. 2008; (2): 382
- A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol. 2007; (1): 177-80
- Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007; (1): 12-9
- Eritrean women's project response to Wall paper: "Hard questions concerning fistula surgery in Third World countries". J Womens Health (Larchmt). 2007; (2): 281-2
Help